PHOENIX, Ariz. - March 17, 2009 - Dr. Daniel Von Hoff, Physician-In-Chief of the
Translational Genomics Research Institute (TGen), has won an award recognizing
his achievements in cancer research.
Dr. Von Hoff, who also is Chief Scientific Officer of TGen Clinical Research
Services at Scottsdale Healthcare, will be recognized in the category of Health
Care Research in a special report this month in Arizona Business Magazine. Dr.
Von Hoff was honored March 4 at the magazine's 2009 Health Care Leadership
Awards at the Ritz Carlton Phoenix.

This is the second major award in recent months for Dr. Von Hoff, a
world-renowned cancer scientist and one of the leading experts in pancreatic
cancer. In November, Dr. Von Hoff was named Arizona's Community Service Leader
of the Year at the 2008 Governor's Celebration of Innovation, presented annually
for contributions to Arizona's technology industry through relentless community
involvement, leadership, visibility and excellence in economic development
activity.

For more than 30 years, Dr. Von Hoff has dedicated his time and experience to
the study of cancer and treatment methods. Arizona Business Magazine cited his:

International leadership in bringing to patients new anti-cancer agents – many
of which have been shown to increase patient survival.

Study of pancreatic and other forms of cancer.
Dedication to teaching.

Entrepreneurial research efforts, which have led to 12 patents.
Through the three-year-old partnership between TGen and Scottsdale Healthcare,
Dr. Von Hoff leads a nearly 40-member staff in the research and treatment of
cancer. TCRS at Scottsdale Healthcare is conducting 35 ongoing studies,
involving the treatment of many patients with advanced cancer. The alliance
works to identify new anti-cancer agents, and strives to bring diagnostic and
treatment options to patients as fast as possible.

Dr. Von Hoff earned his medical degree from Columbia College of Physicians and
Surgeons. He held an internship and residency at the University of California,
San Francisco; conducted four years of cancer research at the National Cancer
Institute; and worked as a faculty member at the University of Texas.

In Arizona, he has worked as Director of the Arizona Cancer Center in Tucson and
as a Clinical Professor at the University of Arizona College of Medicine.

Dr. Von Hoff holds a presidential appointment to the National Cancer Advisory
Board, is widely published and has been a keynote speaker at numerous national
and international medical and scientific conferences.

About TGen
The Translational Genomics Research Institute (TGen) is a non-profit
organization dedicated to conducting groundbreaking research with life changing
results. Research at TGen is focused on helping patients with diseases such as
cancer, neurological disorders and diabetes. TGen is on the cutting edge of
translational research where investigators are able to unravel the genetic
components of common and complex diseases. Working with collaborators in the
scientific and medical communities, TGen believes it can make a substantial
contribution to the efficiency and effectiveness of the translational process.
For more information, visit: www.tgen.org.